Free Trial

Hyperfine (NASDAQ:HYPR) Stock Price Up 0.5% - Should You Buy?

Hyperfine logo with Medical background
Remove Ads

Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report)'s share price traded up 0.5% during trading on Monday . The company traded as high as $0.75 and last traded at $0.74. 207,294 shares were traded during trading, a decline of 45% from the average session volume of 380,075 shares. The stock had previously closed at $0.73.

Analysts Set New Price Targets

HYPR has been the topic of a number of research reports. Wells Fargo & Company lifted their price objective on Hyperfine from $1.10 to $1.29 and gave the stock an "equal weight" rating in a research note on Tuesday, March 18th. Lake Street Capital initiated coverage on shares of Hyperfine in a research note on Monday, March 24th. They set a "buy" rating and a $1.50 price target on the stock. Finally, B. Riley dropped their price objective on shares of Hyperfine from $1.50 to $1.20 and set a "buy" rating for the company in a research note on Thursday, March 20th.

View Our Latest Stock Report on HYPR

Hyperfine Trading Up 0.5 %

The firm has a market capitalization of $57.32 million, a P/E ratio of -1.29 and a beta of 1.05. The firm has a 50 day moving average price of $0.94 and a 200-day moving average price of $0.97.

Hyperfine (NASDAQ:HYPR - Get Free Report) last issued its quarterly earnings results on Monday, March 17th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.16) by $0.02. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. The company had revenue of $2.32 million during the quarter, compared to the consensus estimate of $2.30 million. During the same period last year, the company earned ($0.15) earnings per share. Research analysts anticipate that Hyperfine, Inc. will post -0.57 earnings per share for the current year.

Institutional Trading of Hyperfine

Institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in shares of Hyperfine during the fourth quarter valued at approximately $25,000. Wealth Enhancement Advisory Services LLC grew its position in Hyperfine by 64.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock valued at $72,000 after acquiring an additional 32,093 shares during the last quarter. Graypoint LLC purchased a new stake in Hyperfine in the fourth quarter worth $44,000. Renaissance Technologies LLC lifted its position in shares of Hyperfine by 32.9% during the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company's stock worth $187,000 after purchasing an additional 52,500 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Hyperfine by 18.7% during the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company's stock valued at $675,000 after purchasing an additional 98,335 shares during the period. Institutional investors own 15.03% of the company's stock.

About Hyperfine

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Remove Ads

Should You Invest $1,000 in Hyperfine Right Now?

Before you consider Hyperfine, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.

While Hyperfine currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Insiders are making big bets on these stocks—should you? Stock buybacks can signal confidence and future growth, and 3 companies are making aggressive moves.

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads